Drug development is a complex process that requires validating the safety, quality and efficacy of new drugs. To ensure positive outcomes, testing must be done at each stage of development according to stringent industry standards and regulations. This is where bioanalytical testing services play a pivotal role by providing reliable data to support various regulatory filings.
What are Bioanalytical Testing Services?
Bioanalytical testing refers to quantitative and qualitative analysis done on biological samples like blood, urine, tissues etc. to study the presence, concentration and breakdown of drugs, drug metabolites, biomarkers and other molecules.
Bioanalytical Testing Services encompass a range of specialized assays and tests conducted by certified clinical research organizations (CROs) and testing laboratories. Some key types include:
- Pharmacokinetic (PK) Testing
PK testing determines how the body affects a particular drug - how it is absorbed, distributed, metabolized and excreted. It is essential for evaluating drug absorption, metabolism, interactions and dosage optimization.
- Bioavailability and Bioequivalence Testing
These tests establish if a drug behaves in the same manner as its reference listed drug in terms of rate and extent of absorption. It is required for approval of generic drug applications.
- Immunogenicity Testing
This determines the immune response generated by biotherapeutics in the human body. It is important for assessing safety of biologics.
- Biomarker Testing
Biomarker analysis identifies and measures biomarkers in biological samples to gain insights into disease mechanisms and drug response variability.
- Method Validation Testing
Method validation establishes that the analytical procedure used is suitable for its intended purpose by confirming accuracy, precision, selectivity, linearity, range and robustness.
Benefits of Outsourcing Bioanalytical Testing
Considering rising costs and complexity of drug development, most pharmaceutical companies outsource their bioanalytical requirements to specialized service providers. Here are some key advantages:
- Expertise and Experience
CRO bioanalytical labs have seasoned scientists, state-of-the-art infrastructure and proven expertise across various therapeutic areas and analytical technologies.
- Quality and Compliance
CROs adhere to strict global quality standards and regulatory guidelines like GLP, GCP, cGMP. They are regularly audited to ensure high quality data generation.
- Cost Savings
Outsourcing eliminates need for in-house set up and maintenance of complex equipment and specialized human resources, significantly reducing costs.
- Flexibility and Scale
CROs can handle small batches as well as large volumes of samples as per client timelines. Their resources are scalable based on project requirements.
- Data Integrity
Sophisticated LIMS systems and stringent SOPs at CROs ensure data is captured, processed and reported accurately as per protocols.
- Regulatory Expertise
CRO regulatory experts assist with compilation and submission of various bioanalytical sections of CTA/IND/NDA/ANDA applications to global health authorities.
Key Considerations When Selecting a CRO
With the bioanalytical testing market growing at an annual rate of 7-10%, there are many service providers to choose from. However, certain factors must be evaluated to ensure right partner selection:
- Experience in Therapeutic Area
Check track record of successfully handling similar projects in past. Specialization adds value.
- Global Presence and Accreditations
Ability to support multinational trials. Preferably GLP certified and inspected periodically.
- Assay Technologies
Assess expertise and portfolio of validated bioanalytical methods like LC-MS/MS, immunoassays etc.
- Project Management Skills
Evaluate customer feedback, success rate of completing projects on time and budget.
- Pricing Models
Compare fully inclusive costs factoring regulatory support, equipment usage and SOP templates.
- Data Integrity Processes
Inspect systems for sample handling, result processing and archival as per regulatory norms.
With quality and timelines assuming utmost importance in drug development, outsourcing bioanalytical testing to a competent partner can significantly accelerate clinical trials and new product approvals. A diligent selection process focusing on technical expertise as well as compliance can potentially solve multiple challenges for sponsors.
Get More Insights On This Topic: Bioanalytical Testing Services
Explore More Related Topic: Global Paclitaxel Injection Market
COVID-19 Impact Analysis on Bioanalytical Testing Services Market report published by Value Market Research provides a detailed market analysis comprising market size, share, value, growth and trends for the period 2020-2027.
Moreover, this market report also covers regional and country markets in detail.The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide.
The major players in the bioanalytical testing services market include Pharmaceutical Product Development, LLC.
(PPD), ICON plc, Covance, Inc., Charles River Laboratories International, Inc., Laboratory Corporation of America, inVentiv Health, SGS SA, Toxikon, Inc., Intertek Group plc, Pace Analytical Services, LLC.
This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.Get more information on "Global Bioanalytical Testing Services Market Research Report" by requesting FREE Sample Copy at https://www.valuemarketresearch.com/contact/bioanalytical-testing-services-market/download-sampleMarket DynamicsThe global bioanalytical testing services market is expanding at a fast pace due to the growing pharmaceutical and biopharmaceutical industry.
The significant growth in bioanalytical testing is attributed to increasing concentration on the analytical testing of biosimilars and biologics, increased applications in clinical trials, a growing trend of outsourcing analytical testing.
The Bioanalytical Testing Services Market research report provides the latest industry data, growth, key segments and future trends on the basis of the detailed study.
This market report also allows you to identify the future opportunity and growth rate of the leading segment based on regions and countries.The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide.
The major players in the bioanalytical testing services market include Pharmaceutical Product Development, LLC.
This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.Get more information on "Global Bioanalytical Testing Services Market Research Report" by requesting FREE Sample Copy athttps://www.valuemarketresearch.com/contact/bioanalytical-testing-services-market/download-sampleMarket DynamicsThe global bioanalytical testing services market is expanding at a fast pace due to the growing pharmaceutical and biopharmaceutical industry.
The significant growth in bioanalytical testing is attributed to increasing concentration on the analytical testing of biosimilars and biologics, increased applications in clinical trials, a growing trend of outsourcing analytical testing.
During the global pandemic COVID0-19 market the bioanalytical testing market is expected to witness prominent growth as the entire healthcare system across the globe is focused on the discovery and development of effective drug solutions to combat the disease.
